| 查看: 200 | 回复: 0 | |||
| 当前主题已经存档。 | |||
lw1966hhh铁杆木虫 (著名写手)
|
[交流]
研究一下路透社对小日本药物市场的分析《Jp Pharm Companies Outlook》
|
||
|
The Japanese Pharmaceutical Companies Outlook: An analysis of key players and growth strategies evaluates the strengths and weaknesses of the top 10 Japanese pharmaceutical firms' strategic and financial positions, marketed portfolios and pipeline compounds. This report will enable you to assess the market dynamics within the Japanese pharma market and understand how companies are positioning themselves at a time of significant change in their domestic market. The Japanese pharmaceutical market is the second largest in the world, behind only the US, with estimated sales of $52bn in 2002. While it makes it an attractive target for Western companies' expansion plans, low market growth (1% in 2002) has made the operating environment increasingly difficult for domestic players. Coupled with ongoing regulatory reforms and drug price cuts, which are largely intended to reduce the government's healthcare bill, Japanese companies are being forced to adapt their operating strategies. http://rapidshare.de/files/28238 ... es_Outlook_2004.pdf |
回复此楼» 猜你喜欢
[求助] 流式死活染 & 单细胞门控设置被质疑，如何优化并解释？
已经有1人回复
-
蛋白稳定性实验与功能实验不一致
已经有11人回复
-
药物学论文润色/翻译怎么收费?
已经有131人回复
-
第4年了，马上40了，可能我与国基确实无缘吧。。。
已经有12人回复
-
2026年申博药学专业
已经有1人回复
